Modelli murini di linfomagenesi. Roberto Chiarle, M.D. Firenze, 24/11/2011

Similar documents
Analysis and Integration of Big Data from Next-Generation Genomics, Epigenomics, and Transcriptomics

CCR Biology - Chapter 9 Practice Test - Summer 2012

Organization and analysis of NGS variations. Alireza Hadj Khodabakhshi Research Investigator

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development

PART 3.3: MicroRNA and Cancer

restriction enzymes 350 Home R. Ward: Spring 2001

7.012 Quiz 3 practice

Regulation of telomeres by mirnas in human cancer

Chapter 8: Recombinant DNA 2002 by W. H. Freeman and Company Chapter 8: Recombinant DNA 2002 by W. H. Freeman and Company

Targeted Therapy What the Surgeon Needs to Know

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer

Recognition of T cell epitopes (Abbas Chapter 6)

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA

Cytogenetics for the Rest of Us: A Primer

Biomedicine The background. The main interest. The tools

Chapter 5: Organization and Expression of Immunoglobulin Genes

Next Generation Sequencing

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

How do plasma cells survive

Human Genome and Human Genome Project. Louxin Zhang

PREDA S4-classes. Francesco Ferrari October 13, 2015

Forensic DNA Testing Terminology

Colorectal cancer xenopatients: A preclinical platform for precision medicine

Recombinant DNA & Genetic Engineering. Tools for Genetic Manipulation

Introduction to transcriptome analysis using High Throughput Sequencing technologies (HTS)

Disclosure. Gene Therapy. Transfer of genes into cells Expression of transferred genes

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College

Activation and effector functions of HMI

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

A novel molecular mechanism involved in cancer development revealed by targeting MafB to hematopoietic progenitors

Lecture 13: DNA Technology. DNA Sequencing. DNA Sequencing Genetic Markers - RFLPs polymerase chain reaction (PCR) products of biotechnology

New generation sequencing: current limits and future perspectives. Giorgio Valle CRIBI - Università di Padova

Haematopoietic Chimerism Analysis after Allogeneic Stem Cell Transplantation

Sahlgrenska universitetssjukhuset

Exploiting science for engineering: BRCA2 targeted therapies

Chapter 2. imapper: A web server for the automated analysis and mapping of insertional mutagenesis sequence data against Ensembl genomes

Leukemia Research Foundation Scientific Research Grant Recipients

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Advances in RainDance Sequence Enrichment Technology and Applications in Cancer Research. March 17, 2011 Rendez-Vous Séquençage

Design of conditional gene targeting vectors - a recombineering approach

Single-Cell DNA Sequencing with the C 1. Single-Cell Auto Prep System. Reveal hidden populations and genetic diversity within complex samples

PhD theses. Dr. Reiniger Lilla. Semmelweis University Doctoral School of Pathology

CURRICULUM VITAE. EDUCATION 10/ /2013 Ph.D. in Molecular Medicine (School of Medicine, University of Torino, Italy)

Molecular and Cell Biology Laboratory (BIOL-UA 223) Instructor: Ignatius Tan Phone: Office: 764 Brown

Understanding the immune response to bacterial infections

Next generation sequencing and proteomics. to study the antibody repertoire. and generate monoclonal antibodies

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

Biological Sciences Initiative. Human Genome

Multiple Myeloma and Colorectal Cancer

Nuove mutazioni nella leucemia mielomonoci/ca cronica

Recombinant DNA Technology

Site-Directed Nucleases and Cisgenesis Maria Fedorova, Ph.D.

Description: Molecular Biology Services and DNA Sequencing

Compiled and/or written by Amy B. Vento and David R. Gillum

Hereditary Ovarian cancer: BRCA1 and BRCA2. Karen H. Lu MD September 22, 2013

PrimePCR Assay Validation Report

Cancer: Cells Behaving Badly

Final Review. Aptamers. Making Aptamers: SELEX 6/3/2011. sirna and mirna. Central Dogma. RNAi: A translation regulation mechanism.

Next generation DNA sequencing technologies. theory & prac-ce

Prof Brian McStay Wellcome Trust Senior Investigator Award April March 2020

Translocation Renal Cell Carcinomas

Analysis of Illumina Gene Expression Microarray Data

Leukemias and Lymphomas: A primer

Genomic instability in cancers and cancer predispositions. Popova Tatiana Inserm U830 Institut Curie

Dal germinale al somatico nella identificazione di tumori ereditari

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry

The Case of Baby Joe by Kristen L.W. Walton Page 1

January 23, SCIENTIFIC PROGRAM

Biotechnology: DNA Technology & Genomics

PRACTICAL APPROACH TO ECOTOXICOGENOMICS

SNP genotyping. Gene expression. And now Solexa sequencing.

The Biological Basis of Cancer. Annie Young, Professor of Nursing, University of Warwick, University Hospitals Coventry and Warwickshire

Overview of Next Generation Sequencing platform technologies

American Cancer Society Extramural Grants

MUTATION, DNA REPAIR AND CANCER

Molecular Computing Athabasca Hall Sept. 30, 2013

Genetic Analysis. Phenotype analysis: biological-biochemical analysis. Genotype analysis: molecular and physical analysis

Data Analysis for Ion Torrent Sequencing

Comparative genomic hybridization Because arrays are more than just a tool for expression analysis

ncounter Leukemia Fusion Gene Expression Assay Molecules That Count Product Highlights ncounter Leukemia Fusion Gene Expression Assay Overview

Department of Food and Nutrition

Gene Cloning. Reference. T.A. Brown, Gene Cloning, Chapman and Hall. S.B. Primrose, Molecular Biotechnology, Blackwell

WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED?

Antibody Structure, and the Generation of B-cell Diversity CHAPTER 4 04/05/15. Different Immunoglobulins

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance

37 2 Blood and the Lymphatic System Slide 1 of 34

Gene Mapping Techniques

Automated DNA sequencing 20/12/2009. Next Generation Sequencing

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology

Types of Cancers [-oma growth ]!

Resolving Cancer Heterogeneity:

Predictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University

Expression and Purification of Recombinant Protein in bacteria and Yeast. Presented By: Puspa pandey, Mohit sachdeva & Ming yu

Targeted. sequencing solutions. Accurate, scalable, fast TARGETED

Systematic discovery of regulatory motifs in human promoters and 30 UTRs by comparison of several mammals

TCRG TCRA/D IGH IGK/L

Recombinant DNA Unit Exam

Transcription:

Modelli murini di linfomagenesi Roberto Chiarle, M.D. Firenze, 24/11/2011

Chromosomal translocations in tumors Translocation are common in many types of tumors and are often considered primary oncogenic events. Clonal translocations are the hallmark of most B and T cell tumors, but are often present in solid tumors, such as carcinomas and sarcomas. Translocations cause aberrant expression of oncogenes which confers a strong selective advantage but factors influencing frequency of translocations before establishment of cellular selection have not been fully elucidated Mouse Chr12 IgH c-myc Mouse Chr15 Campbell et al. Cell 2011

Factors that influence the occurrence of translocations in tumors Mechanistic Factors 1- DSBs formation and frequency 2- Spatial proximity 3- Intra- or Inter-chromosomal joining (DSB repair pathways) Cellular Selection Oncogenic translocations are subject to cellular selective forces, through elements that influence expression of translocated loci and activation of oncogenic pathways

Mechanistic Factors: 1- DSBs formation and frequency Bone marrow Peripheral lymphoid organs (lymph nodes, spleen) DSBs DSBs DSBs BCL2-IgH BCL1-IgH BCL2-IgH c-myc-igh

Mechanistic Factors: 2- Spatial proximity Folding principles of the human genome Lieberman-Aiden, Science 2009

CONTACT-FIRST MODEL DSBs Repair within proximal chromosomes Chromosomal territories DSBs-FIRST MODEL DSBs Repair between distant chromosomes DSBs movement Gostissa, Alt and Chiarle. Annual Rev Immunol, 2011

Mechanistic Factors: 3- Intra- or Inter-chromosomal joining (DSB repair pathways) Gostissa, Alt and Chiarle. Annual Rev Immunol, 2011

IgH Class Switch Recombination

The Yeast I-SceI Meganuclease as a tool to study DSB repair, CSR and Translocations

A ΔSγ1 model (chr. 12) ieµ C µ C δ C γ3 * * 0.5kb C γ1 C γ2b C γ2a C ε C α S µ S γ3 ΔS γ1 S γ2b S γ2a S ε S α B c-myc model (chr. 15) Ex1 **** **** Ex2 Ex3 25x I-SceI Ex1 * Ex2 Ex3 1x I-SceI * I-SceI target sequence Sequencing primer LoxP

High Throughput Genomic Translocation Sequencing (HTGTS)

High Throughput Genomic Translocation Sequencing (HTGTS) I-SceI Induction of DSB Translocation Intramolecular ligation 1 st PCR (enrich) DNA fragmentation by frequent cutter Ligate linker 1 st PCR (enrich) 2 nd nested-pcr (specificity) 2 nd nested-pcr (specificity, sequencing primers) 3 rd PCR (sequencing primers) 454 sequencing 1 st PCR primers 2 nd PCR primers adapter primers method ad-pcr ad-pcr ad-pcr circ-pcr mouse DNA 25x I-Sce I c-myc WT 25x I-Sce I c-myc ΔSγ1 AID-/- - WT 2x I-Sce I 25x I-Sce I c-myc WT huma n DNA K562 K562 K562 K562 mouse junc. 2257 1957 1837 316 huma n junc. 12 11 4 2 background 0.53% 0.56% 0.33% 0.63%

High Throughput Genomic Translocation Sequencing (HTGTS) Control Retrovirus I-SceI Retrovirus

High Throughput Genomic Translocation Sequencing (HTGTS) c-myc locus IgH locus Chiarle et al. Cell, 2011

High Throughput Genomic Translocation Sequencing (HTGTS) from the c-myc locus 1a) Arid5a 1b) Aff3 Minus strand Plus strand Cen 1a 1b 2a) Rapgef1 2b) Traf1 2c) Mmp24 2d) Bcl2l1 2a 2b 4a) Pax5 4b) Hivep3 4a 6a) Clec2d 7a) Il4i1 7b) Apbb1 7c) Il4ra 7d) Il21r 8a) Fcer2a 8a 9a) Fli1 9b) Kirrel3 10a) Tnfaip3 10b) Socs2 10a 11a 11a) Sfi1 12a) 11b) Bcl11a Rad51l1 11c) Ebf1 12b) 11d) GrapDync1h1 11e) Mpdu1 12c) IgH 13a) CD83 13b) Mef2c 14a) Fermt2 16a) Lrrc33 18a) Zfp608 17a) Pim1 17b) mir-715 Tel 2cd 4b 6a 7a 7b 7cd 9a 9b 10b 11b 11c 11d 11e 12 a 12 b 13 a 13 b 14 a 16 a 17 a 17 b 18 a 19 a 19a) Scd2 X a Xa) Gucy2f 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 X c-myc Chiarle et al. Cell, 2011

High Throughput Genomic Translocation Sequencing (HTGTS) from the IgH locus (489) (282) 10kb WT * ΔSγ1/ 2x I-SceI Iµ Sµ-Cµ Sγ3 Sγ2a Sγ2b Iε Sε-Cε Sα AID-/- Iγ1 Sγ1-Cγ1 Chiarle et al. Cell, 2011

High Throughput Genomic Translocation Sequencing (HTGTS) Hotspots Iµ-Sµ-Cµ Iε-Sε-Cε Iγ1-Sγ1-Cγ1 Mmp24 Il4ra CD83 Pim1 mir-715 region Fermt2 Gm12493 Aff3 Kirrel3 Apbb1 Jκ Chr1: 137751794 Il21r Rapgef1 Fcer2a Arid5a Il4i1 Chr4: 44725759 Pax5 Clec2d Gucy2f Sfi1 Grap Fli1 Traf1 Chr1: 31667495 Bcl11a Rad51l1 Tnfaip3 Scd2 Zfp608 Sh3bp5 Socs2 Hivep3 Ebf1 Mef2c Dync1h1 Lrrc33 Bcl2l1 Mpdu1 Itpk1 WT AID-/- Chiarle et al. Cell, 2011

Promoter and transcription dependency of translocations WT AID-/- Chiarle et al. Cell, 2011

Promoter and transcription dependency of translocations Chr7: 89Kb Chr13: 27Kb Chr1: 63Kb AID / Junc=ons (1) (0) (6) (1) WT Junc=ons (35) (6) (30) (19) sense An= sense Il4ra Il21r CD83 Aff3 Chiarle et al. Cell, 2011

CERMS Center for Experimental Research and Medical Studies University of Torino, Italy Giorgio Inghirami Claudia Voena Cinzia Martinengo Chiara Ambrogio Cristina Mastini Mara Compagno Matteo Menotti Roberta Pulito Roberto Piva Ramesh Choudhari Silvia Peola Maria Stella Scalzo PCMM Children s Hospital IDI - Immune Disease institute Fred W. Alt Monica Gostissa Richard Frock Darienne Myers Susanna Lewis Daniel Malkin Yu Zhang Molecular Biotechnology Center University of Torino, Italy Guido Forni Federica Cavallo Emilio Hirsch Silvio Aime Dario Longo Lorenzo Silengo Fiorella Altruda